Prescription Drug Monitoring Programs
"Prescription Drug Monitoring Programs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Programs, usually run by state governments, that require pharmacists to collect and distribute data on the prescription and dispensation of CONTROLLED SUBSTANCES. They are intended to prevent the abuse of such substances by the patient, or their transfer to recreational users and drug dealers.
| Descriptor ID |
D000073958
|
| MeSH Number(s) |
E05.337.800.800 N02.421.668.320.600
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prescription Drug Monitoring Programs".
Below are MeSH descriptors whose meaning is more specific than "Prescription Drug Monitoring Programs".
This graph shows the total number of publications written about "Prescription Drug Monitoring Programs" by people in this website by year, and whether "Prescription Drug Monitoring Programs" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prescription Drug Monitoring Programs" by people in Profiles.
-
Adalbert JR, Syal A, Varshney K, George B, Hom J, Ilyas AM. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020. BMC Health Serv Res. 2023 Apr 13; 23(1):364.
-
Siegel N, Lambrechts MJ, Minetos P, Karamian BA, Nourie B, Curran J, Wang J, Canseco JA, Woods BI, Kaye D, Hilibrand AS, Kepler CK, Vaccaro AR, Schroeder GD. The Effect of Online Prescription Drug Monitoring on Opioid Prescription Habits After Elective Single-level Lumbar Fusion. J Am Acad Orthop Surg. 2022 11 01; 30(21):e1411-e1418.
-
Tan TL, Rondon AJ, Wilt Z, Wang WL, Kalbian I, Foltz C, Beredjiklian PK, Arnold WV. Understanding Opioid Use After Total Hip Arthroplasty: A Comprehensive Analysis of a Mandatory Prescription Drug Monitoring Program. J Am Acad Orthop Surg. 2020 Oct 15; 28(20):e917-e922.
-
Hozack BA, Rivlin M, Graham J, Lutsky KF, Beredjiklian PK. Validation of the prescription drug monitoring program Web site. J Opioid Manag. 2019 Nov/Dec; 15(6):495-498.